Yabao Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.27%

Yabao Pharmaceutical Group Co Ltd (600351) has an Asset Resilience Ratio of 0.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Yabao Pharmaceutical Group Co Ltd (600351) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥8.96 Million
≈ $1.31 Million USD Cash + Short-term Investments

Total Assets

CN¥3.34 Billion
≈ $489.15 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2003–2020)

This chart shows how Yabao Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600351 asset base.

Liquid Assets Composition Over Time

This chart breaks down Yabao Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600351 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥8.96 Million 0.27%
Total Liquid Assets CN¥8.96 Million 0.27%

Asset Resilience Insights

  • Limited Liquidity: Yabao Pharmaceutical Group Co Ltd maintains only 0.27% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Yabao Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Yabao Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM
Drug Manufacturers - Specialty & Generic 2.79%
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Beijing Tongrentang Co Ltd
SHG:600085
Drug Manufacturers - Specialty & Generic 2.51%
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
Drug Manufacturers - Specialty & Generic 3.47%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Harbin Pharmaceutical Group Co Ltd
SHG:600664
Drug Manufacturers - Specialty & Generic 0.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%

Annual Asset Resilience Ratio for Yabao Pharmaceutical Group Co Ltd (2003–2020)

The table below shows the annual Asset Resilience Ratio data for Yabao Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2020-12-31 0.00% CN¥100.00K
≈ $14.63K
CN¥4.01 Billion
≈ $587.42 Million
-0.34pp
2018-12-31 0.35% CN¥16.69 Million
≈ $2.44 Million
CN¥4.83 Billion
≈ $706.23 Million
+0.21pp
2016-12-31 0.14% CN¥5.76 Million
≈ $843.34K
CN¥4.21 Billion
≈ $615.40 Million
+0.11pp
2014-12-31 0.02% CN¥785.00K
≈ $114.87K
CN¥3.18 Billion
≈ $466.07 Million
-0.37pp
2013-12-31 0.40% CN¥12.69 Million
≈ $1.86 Million
CN¥3.20 Billion
≈ $468.60 Million
+0.34pp
2012-12-31 0.06% CN¥1.70 Million
≈ $248.05K
CN¥2.88 Billion
≈ $422.08 Million
+0.01pp
2008-12-31 0.04% CN¥735.70K
≈ $107.66K
CN¥1.67 Billion
≈ $245.00 Million
-0.14pp
2005-12-31 0.18% CN¥2.04 Million
≈ $298.95K
CN¥1.13 Billion
≈ $166.06 Million
-0.04pp
2004-12-31 0.22% CN¥2.09 Million
≈ $305.97K
CN¥937.81 Million
≈ $137.23 Million
+0.19pp
2003-12-31 0.03% CN¥200.01K
≈ $29.27K
CN¥664.93 Million
≈ $97.30 Million
--
pp = percentage points

About Yabao Pharmaceutical Group Co Ltd

SHG:600351 China Drug Manufacturers - Specialty & Generic
Market Cap
$692.63 Million
CN¥4.73 Billion CNY
Market Cap Rank
#10779 Global
#2983 in China
Share Price
CN¥6.84
Change (1 day)
-1.58%
52-Week Range
CN¥5.70 - CN¥7.27
All Time High
CN¥14.53
About

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 a… Read more